Nektar TherapeuticsNKTRNASDAQ
Loading
P/E Ratio: Premium ValuationElevated
Percentile Rank71
Studio
Year-over-Year Change

Price-to-earnings ratio

Latest
-4.35
↑ 66% vs avg
Percentile
P71
Within normal range
Streak
2 yr
Consecutive declineElevated
Average
-12.64
Historical baseline
PeriodValueYoY Change
2025-4.35-170.4%
2024-1.61-313.2%
2023-0.39+66.1%
2022-1.15+75.7%
2021-4.73+30.8%
2020-6.83+20.3%
2019-8.57-198.7%
20188.69+109.0%
2017-96.32-763.5%
2016-11.15-